Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: Combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee

International Journal of Cancer

Volumn 128, Issue 5, 2011, Pages 1232-1239

  Rodeberg, David A ^a   Anderson, James R ^b   Arndt, Carola A ^c   Ferrer, Fernando A ^d   Raney, Richard Beverly ^e   Jenney, Meriel E ^f   Brecht, Ines B ^g   Koscielniak, Ewa ^g   Carli, Modesto ^h   Bisogno, Gianni ^h   Oberlin, Odile ⁱ   Rey, Annie ⁱ   Ullrich, Fred ^b   Stevens, Michael C G ^j   Meyer, William H ^k  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f LLANDOUGH HOSPITAL   (United Kingdom)

^g OLGAHOSPITAL   (Germany)

^h UNIVERSITY HOSPITAL OF PADOVA   (Italy)

ⁱ INSTITUT GUSTAVE ROUSSY   (France)

^j UNIVERSITY OF BRISTOL   (United Kingdom)

^k UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

more..

Author keywords

bladder; outcomes; pediatric; prostate; rhabdomyosarcoma

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG TREATMENT FAILURE; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RHABDOMYOSARCOMA; TUMOR VOLUME;

ALGORITHMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; RHABDOMYOSARCOMA; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 78249278036     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25444     Document Type: Article

References (48)

1. Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J, Heyn R,. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995; 13: 610-30.
2. Hays DM,. Bladder/prostate rhabdomyosarcoma: results of the multi-institutional trials of the Intergroup Rhabdomyosarcoma Study. Semin Surg Oncol 1993; 9: 520-3.
3. Hays DM, Raney RB, Jr, Lawrence W, Jr, Soule EH, Gehan EA, Teft M,. Bladder and prostatic tumors in the intergroup Rhabdomyosarcoma study (IRS-I): results of therapy. Cancer 1982; 50: 1472-82.
4. Hays DM, Raney RB, Crist WM, Lawrence WW, Jr, Ragab A, Wharam MD, Webber B, Gehan E, Johnston J, Maurer HM,. Secondary surgical procedures to evaluate primary tumor status in patients with chemotherapy-responsive stage III and IV sarcomas: a report from the Intergroup Rhabdomyosarcoma Study. J Pediatr Surg 1990; 25: 1100-5.
5. Arndt C, Rodeberg D, Breitfeld PP, Raney RB, Ullrich F, Donaldson S,. Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma? Results from Intergroup Rhabdomyosarcoma Study IV. J Urol 2004; 171: 2396-403.
6. Soler R, Macedo A, Jr, Bruschini H, Puty F, Caran E, Petrilli A, Garrone G, Srougi M, Ortiz V,. Does the less aggressive multimodal approach of treating bladder-prostate rhabdomyosarcoma preserve bladder function? J Urol 2005; 174: 2343-6.
7. Stevens MC, Rey A, Bouvet N, Ellershaw C, Flamant F, Habrand JL, Marsden HB, Martelli H, Shanchez de Toledo J, Spicer RD, Spooner D, Terrier-Lacombe MJ, et al. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology-SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol 2005; 23: 2618-28.
8. Flamant F, Rodary C, Rey A, Praquin MT, Sommelet D, Quintana E, Theobald S, Brunat-Mentigny M, Otten J, Voute PA, Habrand JL, Martelli H, et al. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. Eur J Cancer 1998; 34: 1050-62.
9. Carli M, Pastore G, Perilongo G, Grotto P, De Bernardi B, Ceci A, Di Tullio M, Madon E, Pianca C, Paolucci G,. Tumor response and toxicity after single high-dose versus standard five-day divided-dose dactinomycin in childhood rhabdomyosarcoma. J Clin Oncol 1998; 6: 654-8.
10. Carli M, Bisogno G, Guglielmi M, Cecchetto G, DeBernardi B, Donfrancesco A, Mancici AF, Cordero di Montezemolo L, Indolfi P, Bagnulo S, Zanetti I, Masiero L, et al. Improved outcome for children with embryonal rhabdomyosarcama (RMS) results of the Italian Cooperative Study (ICS). Med Pediatr Oncol 2000; 35: 191.
11. Treuner J BI, Mattke A, Harms D, Gadner H, Kazanowska B,. Interim report of the CWS-96 Study: results of the treatment for soft tissue sarcomas in childhood. Med Pediatr Oncol 2003; 41.
12. Ruymann FB, Grovas AC,. Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas. Cancer Invest 2000; 18: 223-41.
13. Ortega JA,. A therapeutic approach to childhood pelvic rhabdomyosarcoma without pelvic exenteration. J Pediatr 1979; 94: 205-9.
14. Kaplan WE, Firlit CF, Berger RM,. Genitourinary rhabdomyosarcoma. J Urol 1983; 130: 116-19.
15. Ghavimi F, Herr H, Jereb B, Exelby PR,. Treatment of genitourinary rhabdomyosarcoma in children. J Urol 1984; 132: 313-19.
16. Loughlin KR, Retik AB, Weinstein HJ, Colodny AH, Shamberger RC, Delorey M, Tarbell N, Cassady JR, Hendren WH,. Genitourinary rhabdomyosarcoma in children. Cancer 1989; 63: 1600-6.
17. Heij HA, Vos A, de Kraker J, Voute PA,. Urogenital rhabdomyosarcoma in children: is a conservative surgical approach justified? J Urol 1993; 150: 165-8.
18. Hicks BA, Hensle TW, Burbige KA, Altman RP,. Bladder management in children with genitourinary sarcoma. J Pediatr Surg 1993; 28: 1019-22.
19. Atra A, Ward HC, Aitken K, Boyle M, Dicks-Mireaux C, Duffy PG, Mitchell CD, Plowman PN, Ransley PG, Pritchard J,. Conservative surgery in multimodal therapy for pelvic rhabdomyosarcoma in children. Br J Cancer 1994; 70: 1004-8.
20. Filipas D, Fisch M, Stein R, Gutjahr P, Hohenfellner R, Thuroff JW,. Rhabdomyosarcoma of the bladder, prostate or vagina: the role of surgery. BJU Int 2004; 93: 125-9.
21. Puri DR, Wexler LH, Meyers PA, La Quaglia MP, Healey JH, Wolden SL,. The challenging role of radiation therapy for very young children with rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 2006; 65: 1177-84.
22. Spunt SL, Sweeney TA, Hudson MM, Billups CA, Krasin MJ, Hester AL,. Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors. J Clin Oncol 2005; 23: 7143-51.
23. Yeung CK, Ward HC, Ransley PG, Duffy PG, Pritchard J,. Bladder and kidney function after cure of pelvic rhabdomyosarcoma in childhood. Br J Cancer 1994; 70: 1000-3.
24. Raney B, Jr, Heyn R, Hays DM, Tefft M, Newton WA, Jr, Wharam M, Vassilopoulou-Sellin R, Maurer HM,. Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder and prostate. A report from the Intergroup Rhabdomyosarcoma Study Committee. Cancer 1993; 71: 2387-94.
25. Hays DM, Raney RB, Wharam MD, Wiener E, Lobe TE, Andrassy RJ, Lawrence W, Jr, Johnston J, Webber B, Maurer HM,. Children with vesical rhabdomyosarcoma (RMS) treated by partial cystectomy with neoadjuvant or adjuvant chemotherapy, with or without radiotherapy. A report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee. J Pediatr Hematol Oncol 1995; 17: 46-52.
26. Oehler W, Fiebig D, Lessel A, Harnisch T, Merkle K,. Results of intensive radiotherapy of bladder cancer following transurethral tumor resection. Radiobiol Radiother (Berl) 1989; 30: 39-46.
27. Sack H, Nosbuesch H, Stuetzer H,. Radiotherapy of prostate carcinoma: results of treatment and complications. Radiother Oncol 1987; 10: 7-15.
28. Maier G,. Effects on radiation on the kidney, bladder and prostate. Front Radiat Ther Oncol 1972; 6: 196.
29. Fuller J, Kob D, Fritzsche V, Moller A, Pirlich W,. Results of combined surgical-radiologic therapy of bladder cancer from the point of view of optimizing dose fractionation. Radiobiol Radiother (Berl) 1988; 29: 455-61.
30. Fuller J, Kob D, Fritzsche V,. Autopsy results in surgical- radiotherapeutic treatment of bladder carcinoma-conclusions for optimal radiologic therapy. Radiobiol Radiother (Berl) 1989; 30: 465-71.
31. Quilty PM, Duncan W, Kerr GR,. Results of a randomised study to evaluate influence of dose on morbidity in radiotherapy for bladder cancer. Clin Radiol 1985; 36: 615-18.
32. Lundbeck F, Ulso N, Overgaard J,. Cystometric evaluation of early and late irradiation damage to the mouse urinary bladder. Radiother Oncol 1989; 15: 383-92.
33. Dorr W, Schultz-Hector S,. Early changes in mouse urinary bladder function following fractionated X irradiation. Radiat Res 1992; 131: 35-42.
34. Dorr W, Beck-Bornholdt HP,. Radiation-induced impairment of urinary bladder function in mice: fine structure of the acute response and consequences on late effects. Radiat Res 1999; 151: 461-7.
35. Raney RB, Jr, Crist W, Hays D, Newton W, Ruymann F, Tefft M, Beltangady M,. Soft tissue sarcoma of the perineal region in childhood. A report from the Intergroup Rhabdomyosarcoma Studies I and II, 1972 through 1984. Cancer 1990; 65: 2787-92.
36. Wharam MD, Hanfelt JJ, Tefft MC, Johnston J, Ensign LG, Breneman J, Donaldson SS, Fryer C, Gehan EA, Raney RB, Maurer HM,. Radiation therapy for rhabdomyosarcoma: local failure risk for Clinical Group III patients on Intergroup Rhabdomyosarcoma Study II. Int J Radiat Oncol Biol Phys 1997; 38: 797-804.
37. Audry G OO, Capelli C, Martelli H, Godzinski J, Spicer R,. The role of conservative surgery in bladder/prostate rhabdomyosarcoma: an update of experience of the SIOP. Presented at the European Society of Pediatric Urology, Tours, France, 2000.
38. Martelli H, Haie-Meder C, Branchereau S, Franchi-Abella S, Ghigna MR, Dumas I, Bouvet N, Oberlin O,. Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience. J Pediatr Surg 2009; 44: 190-6.
39. Meza JL, Anderson J, Pappo AS, Meyer WH,. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on Intergroup Rhabdomyosarcoma Studies III and IV: the Children's Oncology Group. J Clin Oncol 2006; 24: 3844-51.
40. Rodary C, Gehan EA, Flamant F, Treuner J, Carli M, Auquier A, Maurer H,. Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: a report from the International Rhabdomyosarcoma Workshop. Med Pediatr Oncol 1991; 19: 89-95.
41. Breneman JC, Lyden E, Pappo AS, Link MP, Anderson JR, Parham DM, Qualman SJ, Wharam MD, Donaldson SS, Maurer HM, Meyer WH, Baker KS, et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma-a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 2003; 21: 78-84.
42. Stevens MCG,. Treatment for childhood rhabdomyosarcoma: the cost of cure. Lancet Oncol 2005; 6: 77-84.
43. Green DM,. The treatment of advanced or recurrent malignant genitourinary tumors in children. Cancer 1987; 60: 602-11.
44. Koscielniak E,. Treatment of soft tissue sarcoma in childhood and adolescence. Cancer Invest 1992; 70: 2557-67.
45. Dantonello TM, Int-Veen C, Winkler P, Leuschner I, Schuck A, Schmidt BF, Lochbuehler H, Kirsch S,., Hallmen E, Veit-Friedrich I, Bielack SS, Niggli F, et al. Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma. J Clin Oncol 2008; 25: 406-13.
46. Johnson DG,. Trends in surgery for childhood rhabdomyosarcoma. Cancer 1975; 35: 916-20.
47. Donaldson SS, Anderson JR,. Rhabdomyosarcoma: many similarities, a few philosophical differences. J Clin Oncol 2005; 23: 2586-7.
48. Raney B, Anderson J, Jenney M, Arndt C, Brecht I, Carli M, Bisogno G, Oberlin O, Rey A, Treuner J, Ullrich F, Stevens M,. Late effects in 164 patients with rhabdomyosarcoma of the bladder/prostate region: a report from the international workshop. J Urol 2006; 176: 2190-4; discussion 2194-5.